DMARDs

Management of Takayasu Arteritis – A 2026 Update

Kermani TA, Tomelleri A, Scaramuzzi D, Jagtap S, Misra DP. Management of Takayasu Arteritis - A 2026 Update. Curr Rheumatol Rep. 2026 Mar 20;28(1):8. doi:[...]

By afschroeder • March 21, 2026

Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

Karpouzas GA, Szekanecz Z, Baecklund E, Mikuls TR, Bhatt DL, Wang C, Sawyerr GA, Chen Y, Menon S, Connell CA, Ytterberg SR, Mortezavi M. Rheumatoid[...]

By sjmartinez • November 9, 2023